News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
16-Feb-2006 - PLIVA d.d. announced a deal in which it has reached agreement with GlaxoSmithKline (GSK) for the purchase of PLIVA - Istrazivaki Institut d.o.o. (PLIVA - Research Institute Ltd.), PLIVA's proprietary R&D arm renowned for its research into macrolides, in Zagreb, Croatia. In May 2005, PLIVA ...
08-Feb-2006 - Aureus Pharma announced that GlaxoSmithKline (GSK) has signed a multi-year license for Aureus Pharma's AurSCOPE Knowledge databases. Researchers at GSK's global research and development centers will gain access to Aureus' Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and ...
29-Nov-2005 - Four medical research projects making impressive advances into the cause, diagnosis, and treatment of life-threatening diseases have been awarded in total over £470,000 by GlaxoSmithKline in their annual medical research awards programme. They are Meningitis UK (research to develop a Meningitis ...
28-Nov-2005 - GlaxoSmithKline (GSK) announced that HYCAMTIN® (topotecan powder for concentration for solution for infusion) received positive opinion from the European Committee for Human Medicinal Products (CHMP) for the treatment of patients with relapsed small cell lung cancer (SCLC) for whom re-treatment ...
22-Nov-2005 - PLIVA d.d. announced that its partner on ondansetron hydrochloride (HCl) orally disintegrating tablets (ODT) in 4 mg and 8 mg strengths, Kali Laboratories, Inc. ("Kali"), a whollyowned subsidiary of Par Pharmaceutical Companies, Inc., has received final approval from the U.S. Food and Drug ...
07-Nov-2005 - GlaxoSmithKline announced a new $1.8 million program to improve and scale up HIV/AIDS healthcare services at 60 facilities in Kenya. The program, a collaboration with AMREF (African Medical and Research Foundation), Elizabeth Glaser Pediatric AIDS Foundation and the National Empowerment Network ...
24-Oct-2005 - GlaxoSmithKline Biologicals (GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) announced a new public-private partnership to develop GSK Biologicals' tuberculosis candidate vaccine Mtb72F/AS02A, which has shown promising results in preclinical studies. In addition, the vaccine ...
19-Feb-2002 - London and Leverkusen, February 18, 2002 -- GlaxoSmithKline PLC (GSK) and Bayer AG today announce that they have entered into an agreement whereby GSK has purchased the rights to a Bayer preclinical development programme of PPAR- gamma modulators. Bay 54-9801, targeted for entry into the clinic ...
16-Nov-2001 - GlaxoSmithKline plc (GSK) and Bayer AG today announce that they have signed a world-wide co-promotion agreement for vardenafil, a new agent in development for the treatment of erectile dysfunction (ED). The US Food and Drug Administration (FDA) is currently assessing an application, submitted ...
14-Sep-2001 - Tanabe Seiyaku Co, Ltd. and GlaxoSmithKline plc (GSK) today announce that they have signed a letter of intent to enter into a broad-ranging global collaboration on the research, development and commercialisation of a series of compounds from Tanabe, which covers a range of potential ...
© 1997-2024 LUMITOS AG, All rights reserved